limit
data
children
pneumonia
mali
object
assess
etiolog
factor
associ
communityacquir
pneumonia
hospit
children
year
age
mali
prospect
hospitalbas
casecontrol
studi
implement
pediatr
depart
gabriel
univers
hospit
bamako
mali
juli
case
children
radiologicallyconfirm
pneumonia
control
hospit
children
without
respiratori
featur
match
age
period
respiratori
specimen
collect
identifi
virus
bacteria
whole
blood
collect
case
factor
associ
pneumonia
assess
multivari
logist
regress
overal
case
control
analyz
femal
median
age
month
among
pneumonia
case
hypoxem
admiss
mortal
pneumonia
case
differ
control
regard
clinic
sign
symptom
term
past
medic
histori
multivari
analysi
nasal
swab
find
disclos
pneumonia
adjust
odd
ratio
aor
confid
interv
ci
human
metapneumoviru
aor
ci
respiratori
syncyti
viru
rsv
aor
ci
influenza
viru
aor
ci
associ
pneumonia
independ
patient
age
gender
plo
one
pneumonia
lead
caus
child
mortal
infecti
diseas
account
estim
million
death
annual
mainli
affect
children
develop
countri
mortal
attribut
pneumonia
decreas
sinc
remain
major
public
health
concern
main
known
caus
pathogen
report
streptococcu
pneumonia
haemophilu
influenza
type
b
respiratori
syncyti
viru
rsv
howev
distribut
vari
season
locat
data
etiolog
epidemiolog
pneumonia
children
develop
countri
still
insuffici
particularli
subsaharan
africa
mali
one
poorest
countri
world
underf
year
mortal
rate
per
live
birth
accord
un
interag
group
child
mortal
estim
estim
among
million
inhabit
year
pneumonia
episod
occur
children
year
age
lead
almost
death
annual
previou
descript
studi
report
pneumonia
frequent
caus
admiss
repres
total
hospit
admiss
howev
detail
inform
avail
clinic
present
etiolog
suspect
pneumonia
case
moreov
control
group
includ
presenc
control
group
children
without
pneumonia
would
allow
better
interpret
microbiolog
find
particularli
nasal
sampl
march
mali
includ
pneumococc
vaccin
routin
immun
program
vaccin
coverag
still
low
studi
object
assess
etiolog
factor
associ
communityacquir
pneumonia
hospit
children
mali
gabriel
univers
hospit
tertiarycar
gener
hospit
locat
bamako
primari
care
hospit
peopl
live
bamako
nation
refer
centr
patient
variou
medic
surgic
special
includ
pediatr
locat
hospit
pediatr
depart
capac
bed
includ
gener
pediatr
unit
neonatalemerg
unit
receiv
sick
children
primari
care
sever
case
refer
healthcar
set
averag
consult
hospit
admiss
occur
pediatr
depart
annual
acut
respiratori
infect
repres
admiss
children
child
hospit
pneumonia
case
hospit
children
fulfil
follow
criteria
cough
andor
dyspnea
tachypnea
character
world
health
organ
children
month
age
breath
rate
cycl
per
minut
children
month
age
breath
rate
cycl
per
minut
absenc
wheez
auscult
first
symptom
appear
within
last
day
radiolog
confirm
pneumonia
per
guidelin
exclus
criterion
case
presenc
wheez
auscult
minor
whose
parent
legal
guardian
declin
sign
inform
consent
statement
control
patient
hospit
surgeri
routin
outpati
practic
environ
age
month
without
symptom
suggest
respiratori
ill
suspicion
infect
site
exclus
criteria
case
control
match
age
year
calendar
date
hospit
admiss
month
take
season
account
thu
patient
recruit
raini
season
may
octob
recruit
dri
season
novemb
april
sampl
collect
first
hour
patient
hospit
nasal
swab
taken
pneumonia
case
control
document
antibiot
usag
histori
urin
sampl
case
broad
spectrum
antibiot
detect
whole
blood
pleural
effus
applic
case
collect
case
whole
blood
distribut
ethylenediaminetetraacet
acid
edta
vial
preserv
dri
tube
serum
specimen
edtawhol
blood
sampl
allow
complet
blood
count
blood
cultur
realtim
multiplex
polymeras
chain
reaction
pcr
assay
identif
staphylococcu
aureu
streptococcu
pneumonia
haemophilu
influenza
type
b
c
reactiv
protein
crp
procalcitonin
pct
measur
quantit
serum
respiratori
specimen
nasal
swab
pleural
effus
character
ftd
respiratori
pathogen
plu
fasttrack
diagnost
luxembourg
base
rtpcr
includ
panel
demograph
characterist
underli
diseas
medic
histori
clinic
examin
enrol
radiolog
find
vaccin
outcom
record
prospect
patient
standard
form
continu
variabl
describ
median
interquartil
rang
iqr
categor
variabl
number
percentag
pneumonia
case
compar
control
mannwhitney
u
test
continu
covari
chi
test
categor
variabl
univari
multivari
logist
regress
analys
perform
assess
factor
associ
pneumonia
multivari
analys
adjust
gender
age
period
per
quarter
pathogen
significantli
associ
increas
risk
pneumonia
concord
serotyp
detect
nasopharyng
sampl
blood
test
kendal
rank
correl
crude
popul
attribut
fraction
paf
calcul
univari
logist
regress
analysi
quantifi
contribut
microorgan
pneumonia
occurr
conceptu
paf
permit
estim
proport
reduct
pneumonia
occurr
would
occur
pathogen
absent
altern
ideal
scenario
formula
follow
pr
c
preval
microorganim
detect
control
crude
odd
ratio
patient
exclud
miss
data
p
consid
signific
test
bilater
statist
analysi
conduct
stata
version
stata
corp
least
case
control
analys
power
detect
odd
ratio
preval
control
exposur
whatev
preval
case
exposur
studi
protocol
inform
consent
statement
clinic
research
form
amend
studi
document
submit
approv
institut
ethic
committe
nation
dethiqu
pour
la
et
le
scienc
de
la
vie
written
inform
consent
obtain
particip
among
enrol
case
conform
inclus
criteria
sampl
one
patient
without
radiolog
confirm
exclud
analysi
among
includ
control
exclud
miss
data
overal
patient
account
pneumonia
case
control
analyz
among
femal
malefemal
gender
ratio
median
age
month
iqr
month
among
patient
pneumonia
refer
anoth
health
center
median
length
hospit
stay
day
iqr
day
total
day
hospit
tabl
median
time
period
first
symptom
hospit
day
iqr
day
four
pneumonia
case
present
ventricular
septal
defect
none
previou
tuberculosi
underli
lung
diseas
among
case
pulmonari
crackl
unilater
bilater
sign
medic
histori
pneumonia
case
includ
sicklecel
anaemia
n
dehydr
n
epilepsi
n
goiter
n
edema
n
pallor
n
trisomi
n
among
patient
took
antibiot
hospit
receiv
amoxicillin
ceftriaxon
amoxicillinclavulan
acid
cotrimoxazol
among
case
test
antibiot
detect
test
urin
posit
popul
sensit
declar
antibiot
use
compar
urin
detect
low
sensit
confid
interv
median
crp
level
admiss
mgl
iqr
mean
mgl
median
pct
level
ngml
iqr
mean
ngml
median
crp
pct
level
higher
hypoxem
compar
nonhypoxem
pneumonia
case
p
p
respect
median
white
blood
cell
count
cellsl
iqr
mean
cellsl
median
neutrophil
percentag
iqr
mean
xray
show
gener
dens
homogen
opacif
patient
interstiti
syndrom
alveolar
infiltr
without
signific
differ
accord
pattern
infect
viral
bacteri
mix
patient
abscess
pneumothorax
pleural
effus
hospit
stay
pneumonia
case
receiv
follow
antibiot
amoxicillin
n
ceftriaxon
n
amoxicillinclavulan
acid
n
ciprofloxacin
n
vancomycin
n
fiftyon
receiv
oxygen
median
length
day
iqr
day
blood
transfus
three
patient
pleural
effus
test
microbi
detect
five
patient
die
lethal
death
directli
relat
pneumonia
patient
tabl
tabl
compar
clinic
sign
symptom
admiss
case
control
underli
condit
biolog
find
pneumonia
case
differ
control
regard
clinic
sign
symptom
well
vital
sign
admiss
term
demograph
factor
past
medic
histori
pneumonia
case
frequent
hypoxem
defin
oxygen
satur
admiss
control
vs
p
pcv
coverag
zero
group
least
microorgan
detect
nasal
swab
case
control
crude
confid
interv
ci
p
overal
case
control
coinfect
cocolon
crude
ci
p
codetect
nasal
swab
pneumonia
rsv
frequent
case
control
respect
case
control
respect
n
vs
n
p
doserespons
relationship
appar
number
microorgan
found
nasal
swab
risk
case
fig
distribut
pneumonia
rsv
differ
season
higher
rate
pneumonia
januaryjun
rsv
julyseptemb
fig
univari
analysi
reveal
pneumonia
human
metapneumoviru
rsv
influenza
viru
detect
nasal
swab
significantli
associ
pneumonia
mali
tabl
multivari
analysi
reinforc
linkag
pathogen
pneumonia
independ
patient
age
gender
period
per
quarter
presenc
pathogen
significantli
coupl
increas
risk
pneumonia
tabl
paf
highest
pneumonia
paf
ci
contribut
human
metapneumoviru
rsv
influenza
lower
paf
ci
ci
ci
respect
fig
report
distribut
pneumococc
serotyp
detect
nasal
swab
case
control
preval
serotyp
pneumonia
case
control
serotyp
vs
p
serotyp
frequent
pneumonia
case
control
vs
p
vs
p
respect
pneumonia
case
pneumonia
posit
patient
aureu
patient
h
influenza
patient
pcr
blood
sampl
detect
patient
pneumonia
detect
pcr
also
pneumonia
nasal
carriag
patient
pneumonia
nasal
carriag
posit
detect
pcr
p
concord
serotyp
detect
nasal
swab
blood
pneumonia
case
high
p
coronaviru
identifi
pleural
effus
patient
microbiolog
find
includ
pneumonia
serotyp
distribut
pcr
nasal
swab
blood
sampl
differ
pneumonia
case
accord
result
urin
antibiot
test
data
shown
blood
cultur
posit
pneumonia
case
microorgan
probabl
relat
contamin
sampl
follow
bacteria
detect
coagulaseneg
staphyloccoci
n
salmonella
spp
n
gramposit
bacilli
n
acinetobact
baumannii
n
aerococcu
viridan
n
enterococcu
faecium
n
granulicatella
elegan
n
staphylococcu
aureu
n
primari
object
prospect
casecontrol
studi
assess
etiolog
factor
associ
communityacquir
pneumonia
hospit
children
mali
nonpcv
popul
observ
pneumonia
human
metapneumoviru
rsv
influenza
main
microbi
agent
associ
pneumonia
among
children
mali
independ
patient
age
gender
period
pathogen
h
influenza
associ
pneumonia
vaccin
rate
bacteria
least
first
dose
case
control
addit
patient
pneumonia
pcr
blood
also
nasal
carriag
frequent
serotyp
posit
pneumonia
test
nasal
sampl
highli
predict
pneumonia
detect
blood
mean
bacteria
frequent
caus
pneumonia
studi
assess
etiolog
pneumonia
subsaharan
africa
howi
et
al
recent
investig
pneumonia
etiolog
children
gambia
observ
pneumonia
lead
caus
high
rate
microbi
agent
codetect
convers
found
viral
pneumonia
predomin
wherea
observ
virus
name
human
metapneumoviru
rsv
influenza
viru
associ
pneumonia
mali
major
differ
studi
sampl
type
lung
aspir
vs
nasal
swab
investig
lack
compar
group
studi
howi
et
al
permit
comparison
microbi
preval
pneumonia
patient
healthi
subject
western
kenya
casecontrol
studi
pneumonia
rsv
influenza
viru
predomin
caus
pneumonia
children
note
almost
similar
result
mali
thu
pneumonia
rsv
could
still
consid
primari
caus
pneumonia
sever
subsharan
african
countri
patient
die
sever
pneumonia
accord
criteria
signific
dyspnea
mark
chest
indraw
sever
hypoxia
two
patient
confirm
pneumococc
pneumonia
two
patient
acut
malnutrit
link
pneumonia
case
death
occur
within
hour
admiss
despit
activ
treatment
antibiot
oxygen
manag
sever
respiratori
distress
often
difficult
context
hospit
assist
ventilatori
support
mortal
higher
recent
birth
cohort
south
africa
similar
report
previous
develop
countri
invas
serotyp
detect
select
pneumonia
case
control
ie
serotyp
associ
risk
pneumonia
previou
studi
serotyp
involv
invas
pneumococc
diseas
mali
found
serotyp
preval
also
link
pneumonia
seri
subsaharan
african
countri
serotyp
describ
preval
serotyp
invas
pneumococc
diseas
second
serotyp
significantli
associ
pneumonia
children
mali
thu
introduct
pcv
routin
immun
program
mali
would
substanti
reduc
pneumonia
caus
pneumonia
serotyp
elicit
pneumonia
would
cover
vaccin
addit
pneumococc
pneumonia
season
similar
observ
previous
burkina
faso
neighbour
countri
higher
incid
dri
season
januari
may
interestingli
among
microbi
agent
associ
pneumonia
virus
human
metapneumoviru
rsv
influenza
viru
self
et
al
recent
observ
pneumonia
casescontrol
studi
implement
hospit
utah
detect
respiratori
syncyti
viru
human
metapneumoviru
influenza
nasopharyng
oropharyng
sampl
patient
pneumonia
probabl
indic
etiolog
role
observ
similar
result
differ
context
despit
dearth
vaccin
pneumococcu
popul
viral
pneumonia
major
segment
pneumonia
burden
treatment
infect
often
problemat
empir
use
antibiot
antivir
consensu
vaccin
develop
particularli
rsv
warrant
prevent
pneumonia
children
moreov
impact
influenza
vaccin
polici
develop
countri
evalu
viru
often
caus
pneumonia
rhinoviru
detect
almost
pneumonia
case
seri
detect
rate
differ
case
control
howev
observ
formal
exclud
rhinoviru
could
play
role
etiolog
pneumonia
jain
et
al
recent
observ
rhinoviru
detect
us
children
communitypneumonia
requir
hospit
larg
studi
howev
control
group
also
possibl
estim
preval
respiratori
detect
children
without
pneumonia
grow
evid
suggest
role
rhinoviru
etiolog
viral
pneumonia
relat
risk
secondari
bacteri
pneumonia
virus
bocaviru
adenoviru
also
equal
preval
case
control
find
exclud
complet
implic
pneumonia
etiolog
children
mali
howev
virus
poorli
describ
caus
agent
pneumonia
children
subsaharan
african
countri
sever
microorgan
detect
pneumonia
case
also
control
clinic
signific
microbi
detect
pcr
problemat
individu
level
detect
pathogen
caus
pneumonia
howev
number
pathogen
predict
risk
pneumonia
suggest
simpl
quantif
speci
detect
would
permit
evalu
pneumonia
risk
popul
level
nasal
sampl
interest
preval
carriag
control
consid
main
strength
studi
prospect
design
inclus
control
permit
us
assess
pneumonia
etiolog
take
account
preval
pathogen
detect
noninfect
patient
first
casecontrol
investig
pneumonia
etiolog
children
mali
strobe
checklist
result
serv
better
manag
pneumonia
children
also
neighbor
countri
data
qualiti
enhanc
central
microbiolog
analysi
emerg
pathogen
laboratori
lyon
franc
addit
analysi
serv
better
focu
multicentr
pneumonia
studi
permit
us
assess
global
etiolog
pneumonia
compar
etiolog
agent
countri
contin
limit
underlin
first
microbiolog
diagnosi
pneumonia
difficult
due
lack
singl
reliabl
test
individu
level
difficult
establish
posit
nasal
swab
denot
etiolog
nasopharyng
colon
particularli
bacteri
agent
pneumonia
high
asymptomat
carriag
howev
popul
level
addit
control
group
permit
evalu
control
preval
carriag
asymptomat
children
pneumonia
etiolog
studi
would
interest
correl
threshold
cycl
ct
valu
obtain
rtpcr
lower
airway
specimen
establish
precis
relationship
posit
nasal
swab
etiolog
pneumonia
accord
microorgan
second
studi
implement
one
hospit
mali
extern
valid
might
limit
howev
gabriel
univers
hospit
refer
center
countri
sourc
popul
limit
citi
bamako
third
studi
power
confin
detect
linkag
ie
serotyp
associ
risk
pneumonia
communityacquir
pneumonia
mainli
attribut
pneumonia
human
metapneumoviru
rsv
influenza
among
children
mali
increas
pneumococc
conjug
vaccin
coverag
children
would
significantli
reduc
burden
pneumonia
countri
addit
control
group
assess
etiolog
pneumonia
children
critic
properli
interpret
microbiolog
result
diagnost
test
high
sensit
support
inform
strobe
checklist
doc
